Clinical Trials on Acquired Pure Red Cell Aplasia
Total 3990 results
-
All4CureJanssen Scientific Affairs, LLCRecruitingMultiple Myeloma | Multiple Myeloma Without Mention of RemissionUnited States
-
Cedars-Sinai Medical CenterPenguin Cold CapsRecruitingMultiple MyelomaUnited States
-
Qilu Pharmaceutical Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina
-
PfizerRecruitingMultiple Myeloma | Non-Hodgkin LymphomaChina
-
Dana-Farber Cancer InstituteJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple MyelomaUnited States
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic DiseaseGreece
-
C4 Therapeutics, Inc.RecruitingMultiple Myeloma | Lymphoma, Non-Hodgkin'sUnited States
-
The Royal Wolverhampton Hospitals NHS TrustUniversity of WolverhamptonRecruiting
-
National Cancer Institute (NCI)Active, not recruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Lymphoma/Leukemia Molecular Profiling Project (LLMPP)CompletedLymphoma, Non-Hodgkin | Leukemia | Multiple Myeloma | Hodgkin LymphomaUnited States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLymphoma | Multiple Myeloma | AmyloidosisUnited States, China, Belgium, Canada, Poland, Spain, Korea, Republic of, Greece, Singapore, Japan, Sweden
-
Janssen Research & Development, LLCActive, not recruitingA Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaMultiple MyelomaUnited States, Australia, France, United Kingdom, Germany, Israel, Turkey, Netherlands, Canada, Russian Federation, Czechia
-
Jonsson Comprehensive Cancer CenterWithdrawnRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenCompletedMultiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | HDT-AHCTUnited States
-
M.D. Anderson Cancer CenterTakeda; Janssen PharmaceuticalsActive, not recruitingRecurrent Primary Amyloidosis | Refractory Primary Amyloidosis | Newly Diagnosed Primary AmyloidosisUnited States
-
University of RochesterAmgenActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterSpectrum Pharmaceuticals, IncActive, not recruitingMultiple Myeloma | AmyloidosisUnited States
-
Kyowa Kirin Co., Ltd.CompletedMultiple Myeloma and Malignant LymphomaJapan
-
BioInvent International ABTerminated
-
Lene Meldgaard KnudsenIO BiotechTerminatedSmoldering Multiple MyelomaDenmark
-
Boston Medical CenterCompleted
-
Sherif S. FaragNational Cancer Institute (NCI)CompletedMultiple Myeloma | Non-Hodgkin's LymphomaUnited States
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Novartis PharmaceuticalsCompletedSmoldering Multiple MyelomaGermany, United States, France
-
Tarix PharmaceuticalsConstant Therapeutics LLCTerminatedLymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin DiseaseUnited States
-
Landspitali University HospitalMemorial Sloan Kettering Cancer Center; Celgene; Amgen; University of IcelandEnrolling by invitationMultiple Myeloma | Smoldering Multiple MyelomaIceland
-
University Hospital, Clermont-FerrandLaboratoires TakedaUnknownMultiple Myeloma | Adult | Bortezomib RegimenFrance
-
Etablissement Français du SangCentre Hospitalier Universitaire de BesanconCompletedLymphoma | Multiple Myeloma | Hodgkin Disease | Lymphocytic Leukemia
-
Assistance Publique - Hôpitaux de ParisUnknownNewly Diagnosed Myeloma Patient Above 65 Years OldFrance
-
University of CologneCompletedMultiple Myeloma | Hodgkin's Disease | Non-Hodgkin-LymphomaGermany
-
Innate PharmaCompletedSmoldering Multiple MyelomaUnited States
-
PETHEMA FoundationCelgene CorporationCompleted
-
Peter MacCallum Cancer Centre, AustraliaJanssen-Cilag Ltd.CompletedMultiple MyelomaAustralia
-
National Cancer Institute (NCI)CompletedArsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple MyelomaUnspecified Adult Solid Tumor, Protocol Specific | Refractory Multiple MyelomaUnited States
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)Completed
-
Centre Leon BerardAmgenCompleted
-
St. Jude Children's Research HospitalRecruitingPancreatic Cancer | Hodgkin Lymphoma | Lynch Syndrome | Tuberous Sclerosis | Fanconi Anemia | AML | Non Hodgkin Lymphoma | Familial Adenomatous Polyposis | Acute Leukemia | Nevoid Basal Cell Carcinoma Syndrome | Neurofibromatosis Type 1 | Neuroblastoma | Retinoblastoma | MDS | Rhabdomyosarcoma | Von Hippel-Lindau Disease | Adrenocortical Carcinoma and other conditionsUnited States
-
Abdullah KhanRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
SCRI Development Innovations, LLCJanssen Research & Development, LLCRecruiting
-
Mayo ClinicRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Oslo University HospitalTargovax ASARecruitingMultiple Myeloma | Smoldering Multiple MyelomaNorway
-
University of RochesterKaryopharm Therapeutics IncRecruitingSmoldering Multiple MyelomaUnited States
-
RenJi HospitalRecruitingOverall Survival | Progression Free Survival | MaintenanceChina
-
University of UtahRecruiting
-
Ascentage Pharma Group Inc.RecruitingMultiple Myeloma | AmyloidosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Rouen; University Hospital, CaenRecruitingQuality of Life | Physical Activity | Multiple MyelomaFrance
-
Medical College of WisconsinRecruitingMultiple Myeloma | Hematological MalignancyUnited States
-
National Cancer Institute (NCI)Janssen Scientific Affairs, LLCActive, not recruiting
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway